DNA methylation-based diagnosis of cancer and identification of novel therapeutic targets [ 2003-01-01 - 2006-08-30 ]

Research Grant

Researchers: Dr Bernard Carroll (Chief Investigator) ,  Emeritus Professor Ross Barnard (Chief Investigator) ,  John Mattick (Chief Investigator)

Brief description DNA methylation-based diagnosis of cancer and identification of novel therapeutic targets. In our aging society, cancer represents a severe economic and quality-of-life threat. DNA methylation switches genes off, and recently, it was shown that defects in DNA methylation contribute to human diseases including cancer. This project will identify defects in DNA methylation associated with cancer. Identifying these defects will enable us to design non-invasive, early diagnostic tests for cancer on blood or bodily excretions, and to pursue novel therapeutic approaches for treating cancer. The expected outcomes would generate exports to markets in the USA and Europe and replace imports of drugs and technology to treat cancer.

Funding Amount $240,000

Funding Scheme Linkage Projects

View this grant in the ARC Data Portal